Indoor golf has blown up lately. But most companies either feel like glorified arcade games or intimidating tech labs designed for data nerds. Golf VX sits somewhere different entirely. Their mission?

Picking a stake in this high-quality artificial intelligence (AI) networking stock can supercharge your portfolio.

Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.

While this involves significant execution risk, there is definitely a chance -- albeit a small one -- that Innodata can ...